Premium
HilleVax Inc (HLVX)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norov... HilleVax Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection. Show more
$189.3 million of cash, cash equivalents and marketable securities as of September 30, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in...
$245.0 million of cash, cash equivalents and marketable securities as of June 30, 2024 The company is exploring the potential for continued development of its HIL-214 and HIL-216 norovirus...
BOSTON, July 31, 2024 (GLOBE NEWSWIRE) -- HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced a...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.215 | -10.1176470588 | 2.125 | 2.135 | 1.915 | 220089 | 2.02434561 | CS |
| 4 | 0 | 0 | 1.91 | 2.15 | 1.83 | 340995 | 1.97574115 | CS |
| 12 | 0.08 | 4.37158469945 | 1.83 | 2.15 | 1.78 | 236259 | 1.95408722 | CS |
| 26 | 0.16 | 9.14285714286 | 1.75 | 2.15 | 1.58 | 362106 | 1.85243301 | CS |
| 52 | -12.72 | -86.9446343131 | 14.63 | 20.22 | 1.55 | 419774 | 4.1575164 | CS |
| 156 | -16.85 | -89.8187633262 | 18.76 | 24.42 | 1.55 | 216631 | 7.23002978 | CS |
| 260 | -16.85 | -89.8187633262 | 18.76 | 24.42 | 1.55 | 216631 | 7.23002978 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
